SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7905Cox-2's What is the possibility that Cox-2's fit Sepr's technology jayhawk969-12/21/2004
7904Question for the thread. Are non-pharmacologic treatments for insomnia comparabArchie Meeties-12/19/2004
7903If biotech investing was like playing tic-tac-toe, I would likely say these guyskenhott-12/17/2004
7902Big Pharma's Rx to Rise and Shine NEWS ANALYSIS By Amy Tsao [BW] Sepracorsim1-12/17/2004
7901Indeed, that is the weirdest downgrade I've ever heard of. There is no posstom pope-12/16/2004
7900S&P heard DS remind his questioner that he said "<b>at least</quidditch-12/16/2004
7899<<<"no operating heavy machinery" aspect of the label justifyrkrw-12/16/2004
7898They probably didn't want to anticipate approval/nonapproval.Michael Young-12/16/2004
7897Sepracor Won't Be Profitable Before 2006 Or 2007 12.16.04, 4:33 PM ET StandIcebrg-12/16/2004
7896This update from the Street.com provides some commentary from SSB's analyst.tuck-12/16/2004
7895Smith Barney and Stanford looking pretty stupid here. Will they admit it and uptuck-12/16/2004
7894From an analyst: The final approval for Sepracor's Lunesta (formerly EstorrRocky9-12/16/2004
7893They said 1.5 MM details and are hoping for Tier II on price lists vs. Tier III Robohogs-12/16/2004
7892CC Random Notes: '05 Lunesta marketing "at least" (Southwell emphquidditch-12/16/2004
7891Going with 10% premium to Ambien and could take 6-9 mos to get on formularies. Robohogs-12/16/2004
7890Label lunesta.comRobohogs-12/16/2004
7889Reading some more notes on approval (various research including MS and JPM and aRobohogs-12/16/2004
7888LUNESTA(TM) Brand Eszopiclone, Formerly ESTORRA, Approved by FDA for Treatment oscaram(o)uche-12/16/2004
7887I am totally hedged and lost some money doing so. MS is out with report highliRobohogs-12/15/2004
7886<i>everyone who is watching it needs the drug.</i> That actually brBiomaven-12/15/2004
7885Reuters is out saying definitively that SEPR has said there is no short-term usaRobohogs-12/15/2004
7884"you can run TV ads at 3 a.m. in the morning," Mr. Southwell says. &quSidney Street-12/15/2004
7883I particularly got a laugh at the last lines in your WSJ article: Sepracor'Robohogs-12/15/2004
7882From the WSJ...... Sepracor Gets FDA Approval To Sell Insomnia Drug By LAURA Jkenhott-12/15/2004
7881Approved. Not much details however. Boy, I am sleepy!kenhott-12/15/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News